{"id":449813,"date":"2025-12-13T13:35:00","date_gmt":"2025-12-13T12:35:00","guid":{"rendered":"https:\/\/medizinonline.com\/nouvelles-recommandations-sur-la-classification-du-risque-de-mcv-la-reduction-des-lipides-en-cas-dintolerance-aux-statines-et-lhofh\/"},"modified":"2025-12-12T23:05:55","modified_gmt":"2025-12-12T22:05:55","slug":"nouvelles-recommandations-sur-la-classification-du-risque-de-mcv-la-reduction-des-lipides-en-cas-dintolerance-aux-statines-et-lhofh","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/nouvelles-recommandations-sur-la-classification-du-risque-de-mcv-la-reduction-des-lipides-en-cas-dintolerance-aux-statines-et-lhofh\/","title":{"rendered":"Nouvelles recommandations sur la classification du risque de MCV, la r\u00e9duction des lipides en cas d&#8217;intol\u00e9rance aux statines et l&#8217;hoFH"},"content":{"rendered":"\n<p><strong>La mise \u00e0 jour du guide de prise en charge des dyslipid\u00e9mies publi\u00e9e par la <em>Soci\u00e9t\u00e9 europ\u00e9enne de cardiologie<\/em> (ESC) et la <em>Soci\u00e9t\u00e9 europ\u00e9enne d&#8217;ath\u00e9roscl\u00e9rose <\/em>(EAS) reste essentiellement ax\u00e9e sur la meilleure fa\u00e7on de contr\u00f4ler les niveaux de lipides afin de r\u00e9duire le risque cardiovasculaire (CV). Bien que certaines choses restent inchang\u00e9es, de nouvelles recommandations importantes ont \u00e9t\u00e9 ajout\u00e9es, bas\u00e9es sur des preuves issues de plusieurs \u00e9tudes cliniques publi\u00e9es \u00e0 partir de 2019. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fnouvelles-recommandations-sur-la-classification-du-risque-de-mcv-la-reduction-des-lipides-en-cas-dintolerance-aux-statines-et-lhofh%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La mise \u00e0 jour du guide de prise en charge des dyslipid\u00e9mies publi\u00e9e par la Soci\u00e9t\u00e9 europ\u00e9enne de cardiologie (ESC) et la Soci\u00e9t\u00e9 europ\u00e9enne d&#8217;ath\u00e9roscl\u00e9rose (EAS) reste essentiellement ax\u00e9e sur&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fnouvelles-recommandations-sur-la-classification-du-risque-de-mcv-la-reduction-des-lipides-en-cas-dintolerance-aux-statines-et-lhofh%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":449814,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Gestion des lipides : mise \u00e0 jour des lignes directrices ESC\/EAS 2025","footnotes":""},"category":[11378,11404,11527,11535,11549],"tags":[86960,72468,15914,15916,69210,86962,18273],"powerkit_post_featured":[],"class_list":["post-449813","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiologie","category-endocrinologie-et-diabetologie","category-etudes","category-rapports-de-congres","category-rx-fr","tag-classification-des-risques-cvd","tag-cvd-fr","tag-dyslipidemie-fr","tag-gestion-des-lipides","tag-intolerance-aux-statines-fr","tag-mise-a-jour-des-lignes-directrices-esc-eas-2025","tag-reduction-des-lipides","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-28 13:38:02","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":449807,"slug":"nuove-raccomandazioni-sulla-classificazione-del-rischio-cvd-sullabbassamento-dei-lipidi-nellintolleranza-alle-statine-e-sullhofh","post_title":"Nuove raccomandazioni sulla classificazione del rischio CVD, sull'abbassamento dei lipidi nell'intolleranza alle statine e sull'hoFH","href":"https:\/\/medizinonline.com\/it\/nuove-raccomandazioni-sulla-classificazione-del-rischio-cvd-sullabbassamento-dei-lipidi-nellintolleranza-alle-statine-e-sullhofh\/"},"pt_PT":{"locale":"pt_PT","id":449802,"slug":"novas-recomendacoes-sobre-classificacao-do-risco-de-dcv-reducao-dos-lipidos-em-caso-de-intolerancia-as-estatinas-e-hofh","post_title":"Novas recomenda\u00e7\u00f5es sobre classifica\u00e7\u00e3o do risco de DCV, redu\u00e7\u00e3o dos l\u00edpidos em caso de intoler\u00e2ncia \u00e0s estatinas e hoFH","href":"https:\/\/medizinonline.com\/pt-pt\/novas-recomendacoes-sobre-classificacao-do-risco-de-dcv-reducao-dos-lipidos-em-caso-de-intolerancia-as-estatinas-e-hofh\/"},"es_ES":{"locale":"es_ES","id":449799,"slug":"nuevas-recomendaciones-sobre-la-clasificacion-del-riesgo-de-ecv-la-reduccion-de-lipidos-en-caso-de-intolerancia-a-las-estatinas-y-la-hofh","post_title":"Nuevas recomendaciones sobre la clasificaci\u00f3n del riesgo de ECV, la reducci\u00f3n de l\u00edpidos en caso de intolerancia a las estatinas y la hoFH","href":"https:\/\/medizinonline.com\/es\/nuevas-recomendaciones-sobre-la-clasificacion-del-riesgo-de-ecv-la-reduccion-de-lipidos-en-caso-de-intolerancia-a-las-estatinas-y-la-hofh\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/449813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=449813"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/449813\/revisions"}],"predecessor-version":[{"id":449815,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/449813\/revisions\/449815"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/449814"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=449813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=449813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=449813"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=449813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}